The Committee for Medicinal Products for Human Use recommends marketing approval for Merck's Keytruda for treating two types ...

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

Shares of Merck & Co. Inc. MRK shed 1.31% to $115.63 Monday, on what proved to be an all-around great trading session for the ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Merck & Company (MRK – Research Report), ...

Headlines,Wall Street analysts show strong enthusiasm for Merck, (NYSE:MRK),, with the average brokerage recommendation (ABR) ...

Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $117.96 which represents a slight increase of $2.10 or 1.81% from the prior close of $115.86. The stock opened at $115.8 and touched a ...

Thank you for attending our Global Healthcare Conference. Today, I have the pleasure to host Joe Romanelli, President of Human Health International; and Peter Dannenbaum, Head of Investor Relations.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...